European Biodefense Market size to hit $6.3 Bn by 2028

Published Date: 2022-05-17

Request a sample

European Biodefense Market size is expected to surpass USD 6.3 billion by 2028, according to a latest forecast report by Graphical Research.

Rising R&D investments by the government will augment the overall market progression. Growing global biological threats have necessitated the need for funds to support R&D activities. As a result, increased R&D investments enable pharmaceutical and biopharmaceutical companies to produce superior quality and technologically advanced biothreat detection devices, which should have a significant impact on the industry. Moreover, to combat virus attacks, organizations and associations involved in biodefense activities, stock large quantities of bio-threat detection devices and vaccines. Also, European government introduces various strategy for public security. For instance, in 2018, the UK government released the Strategic Defense and Security Review, the Strategy for UK Life Sciences, Global Health Security and UK Antimicrobial Resistance Strategy, the National Counterterrorism Strategy, and Biological Security Strategy. Such initiatives of government worldwide open a window of opportunities for the firms involved in the biodefense sector.

Based on product is bifurcated into vaccines, and biothreat detection devices.  Vaccines are further segmented into smallpox, anthrax, botulism, and others. Whereas biothreat detection devices are further segmented into samplers, assays, reagents, detectors/triggering devices, and identifiers. Among these, the biothreat detection devices segment accounted for around 36% market share in 2021. This is attributed to the growing usage of biothreat detection devices such as identifiers in Europe. A biological agent identifier is a device that detects biological agents with high accuracy. Common biothreat agents detected by identifier include botulinum toxin, smallpox, ricin, anthrax, black plague, and tularemia. It has also been shown to detect SARS-CoV-2 in the air. Additionally, significant investments offered by the private and public sectors for research and development activities as well as the high precision and functionality offered by these instruments will increase their demand in the near future. Furthermore, the widespread availability of advanced biothreat detection devices to ensure the public's security and safety will accelerate the segmental progression.

Browse detailed statistical insights from the report, “Europe Biodefense Market Forecast 2028 By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}), Research Report, Country Outlook (Germany, UK, France, Spain), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

https://www.graphicalresearch.com/industry-insights/2112/europe-biodefense-market

The Germany biodefense industry will exhibit 7.5% CAGR over the projected timeline. Germany is one of the leading markets for biodefense in the Europe region. The market growth is due to the widespread use of technologically advanced biothreat detection devices for detecting infections caused by the release of bacteria and pathogens. Moreover, growing concerns associated with the bioterrorism attacks coupled with the presence of modern healthcare infrastructure will spur the country-level biodefense business growth in forthcoming years. Also, major market players have undertaken R&D efforts to manufacture biodefense detection devices enabling accurate and rapid detection.

The biodefense in European market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:

Europe Market, By Product

  • Vaccines
    • Anthrax
    • Smallpox
    • Botulism
    • Others
  • Biothreat Detection Devices
    • Samplers
    • Detectors/Triggering Devices
    • Identifiers
    • Assays and Reagents

The above information has been provided for the following countries:

  • Europe 
    • Germany
    • UK
    • France
    • Spain
    • Others